Pioglitazone is an antihyperglycemic used as an adjunct to diet, exercise, and other antidiabetic medications to manage type 2 diabetes mellitus. It is administered as a racemic mixture, though there is no pharmacologic difference between the enantiomers and they appear to interconvert in vivo with little consequence. It is grouped under the following drug class(es): Hypoglycemics and Thiazolidinediones. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Glustin, Zactos, Pioglitazona and Piozone. Its PubChem CID is 4829.
Pioglitazone
| CAS No | 111025-46-8 |
|---|---|
| Molecular Formula | C19H20N2O3S |
| Molecular Weight | 356.4 g/mol |
| Synonyms | 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pioglitazone is an antihyperglycemic used as an adjunct to diet, exercise, and other antidiabetic medications to manage type 2 diabetes mellitus. It is administered as a racemic mixture, though there is no pharmacologic difference between the enantiomers and they appear to interconvert in vivo with little consequence.
The listed CAS number is 111025-46-8.
The listed molecular formula is C19H20N2O3S.
The listed molecular weight is 356.4 g/mol.
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione.
The source lists Glustin, Zactos, Pioglitazona and Piozone.